Show simple item record

dc.contributor.authorNavarro Sánchez, Mónica
dc.contributor.authorGil-Miravet, Isis
dc.contributor.authorMontero Caballero, Daniel
dc.contributor.authorBathgate, Ross A. D.
dc.contributor.authorHossain, Mohammed Akhter
dc.contributor.authorCastillo-Gómez, Esther
dc.contributor.authorGundlach, Andrew Lawrence
dc.contributor.authorOlucha-Bordonau, Francisco E
dc.date.accessioned2024-06-14T06:17:52Z
dc.date.available2024-06-14T06:17:52Z
dc.date.issued2024-07
dc.identifier.citationM. Navarro-Sánchez, I. Gil-Miravet, D. Montero-Caballero, R. A.D. Bathgate, M. A. Hossain, E. Castillo-Gómez, A. L. Gundlach, F. E. Olucha-Bordonau, Modulation of contextual fear acquisition and extinction by acute and chronic relaxin-3 receptor (RXFP3) activation in the rat retrosplenial cortex, Biochem. Pharmacol. 225 (2024) 116264, https://doi.org/10.1016/j.bcp.2024.116264ca_CA
dc.identifier.isbn0006-2952
dc.identifier.issn1873-2968
dc.identifier.urihttp://hdl.handle.net/10234/207816
dc.description.abstractThe retrosplenial cortex (RSC) plays a central role in processing contextual fear conditioning. In addition to corticocortical and thalamocortical projections, the RSC receives subcortical inputs, including a substantial projection from the nucleus incertus in the pontine tegmentum. This GABAergic projection contains the neuropeptide, relaxin-3 (RLN3), which inhibits target neurons via its Gi/o-protein-coupled receptor, RXFP3. To assess this peptidergic system role in contextual fear conditioning, we bilaterally injected the RSC of adult rats with an adeno-associated-virus (AAV), expressing the chimeric RXFP3 agonist R3/I5 or a control AAV, and subjected them to contextual fear conditioning. The R3/I5 injected rats did not display any major differences to control-injected and naïve rats but displayed a significantly delayed extinction. Subsequently, we employed acute bilateral injections of the specific RXFP3 agonist peptide, RXFP3-Analogue 2 (A2), into RSC. While the administration of A2 before each extinction trial had no impact on the extinction process, treatment with A2 before each acquisition trial resulted in delayed extinction. In related anatomical studies, we detected an enrichment of RLN3-immunoreactive nerve fibers in deep layers of the RSC, and a higher level of co-localization of RXFP3 mRNA with vesicular GABA transporter (vGAT) mRNA than with vesicular glutamate transporter-1 (vGLUT1) mRNA across the RSC, consistent with an effect of RLN3/RXFP3 signalling on the intrinsic, inhibitory circuits within the RSC. These findings suggest that contextual conditioning processes in the RSC involve, in part, RLN3 afferent modulation of local inhibitory neurons that provides a stronger memory acquisition which, in turn, retards the extinction process.ca_CA
dc.description.sponsorShipFunding for open access charge: CRUE-Universitat Jaume I
dc.format.extent15 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherElsevierca_CA
dc.relationDesarrollo de sistemas peptidérgicos relacionados con comportamiento social. la interacción relaxin3-oxitocinaca_CA
dc.relation.isPartOfBiochemical Pharmacology, 2024, vol. 225ca_CA
dc.rightsCopyright © 2024 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ca_CA
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/ca_CA
dc.subjectneuropeptide modulationca_CA
dc.subjectG-protein-coupled receptor (GPCR)ca_CA
dc.subjectemotionca_CA
dc.subjectGABAca_CA
dc.subjectglutamateca_CA
dc.subjectexcitatory/inhibitory balanceca_CA
dc.titleModulation of contextual fear acquisition and extinction by acute and chronic relaxin-3 receptor (RXFP3) activation in the rat retrosplenial cortexca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.1016/j.bcp.2024.116264
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_CA
dc.relation.publisherVersionhttps://www.sciencedirect.com/science/article/pii/S0006295224002478ca_CA
dc.description.sponsorshipThis research was funded by the UJI predoctoral program PREDOC/2021/19 (MN-S), the UJI postdoctoral program POSDOC/2021/19 (IG-M); Fundación Alicia Koplowitz, Spain, grant number 19I436 (FEO-B, EC-G); the Spanish Ministerio de Ciencia, Innovación y Universidades, grant number RTI2018-095698-B-I00 (FEO-B, IG-M, EC-G); AICO Generalitat Valenciana, grant number AICO/2021/246 (EC-G, FEO-B), the Plan Nacional sobre Drogas of the Spanish Ministerio de Sanidad y Consumo grant number 2020I012 (FEO-B and EC-G) and UJI-B2019-54 (FEO-B). Studies at the Florey Institute were supported by the Victorian Government's Operational Infrastructure Support Program.
dc.description.sponsorshipSupported by Red Española de Investigación en Estrés/Spanish Network for Stress Research RED2022-134191-T financed by MCIN/AEI /10.13039/501100011033. We are indebted to the confocal facility and animal facility (SEA) of the Servicio Central de Instrumentación Científica (SCIC) of UJI and Victoria Ibáñez from the Statistics Department UJI.
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA
project.funder.identifierhttp://dx.doi.org/10.13039/501100011033ca_CA
project.funder.nameMinisterio de Ciencia, Innovación y Universidadesca_CA
project.funder.nameMinisterio de Ciencia e Innovaciónca_CA
project.funder.nameUniversitat Jaume Ica_CA
project.funder.nameFundación Alicia Koplowitzca_CA
project.funder.nameGeneralitat Valencianaca_CA
project.funder.namePlan Nacional sobre Drogas (Ministerio de Sanidad y Consumo)ca_CA
oaire.awardNumberMICIU/ICTI2017-2020/RTI2018-095698-B-I00ca_CA
oaire.awardNumberRED2022-134191-Tca_CA
oaire.awardNumberPREDOC/2021/19ca_CA
oaire.awardNumberPOSDOC/2021/19ca_CA
oaire.awardNumberUJI-B2019-54ca_CA
oaire.awardNumber19I436ca_CA
oaire.awardNumberAICO/2021/246ca_CA
oaire.awardNumber2020I012ca_CA


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Copyright © 2024 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Except where otherwise noted, this item's license is described as Copyright © 2024 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).